Regeneron Ventures will invest in biopharmaceutical and healthcare technology startups.

The future of the pharmaceutical supply chain lies in the ability to predict, prescribe, and automate, says Joe Volpe, managing director of MSD Global Health Innovation Fund.

While generative AI is the word on every investor's lips, hospital systems are still far from being able to benefit from this technology. The biggest hurdle to overcome? IT systems.

The UK-headquartered health insurer has set up a A$20m fund in Australia to back young startups in healthcare areas like genomics and wearables.

Three companies have led the pack in microbiome startup investments over the past five years. This is who they are and what they invest in.

Sid Siddeek has turned Nvidia's NVentures into one of the world's most active CVCs, and he says drug development is just one area AI will transform.

A few months after LG Tech Ventures lifted its capital to $768m, the parent firm has backed Vista to seek AI, bio and automotive companies.

Kyocera Ventures Innovation Fund I will back developers of technologies including energy, mobility AI, chips and nuclear fusion.

Bharat Rajaram will serve as the managing director and head of Aflac Global Ventures.